Join to View Full Profile
55 Fruit StYawkey 9eBoston, MA 02114
Phone+1 617-724-8770
Dr. Gerstner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Residency, Neurology, 2003 - 2006- New York Presbyterian Hospital (Cornell Campus)Internship, Internal Medicine, 2002 - 2003
Columbia University Vagelos College of Physicians and SurgeonsClass of 2002
Certifications & Licensure
MA State Medical License 2006 - 2027
NH State Medical License 2023 - 2025
American Board of Psychiatry and Neurology Neurology
Clinical Trials
- MRI Scans in Evaluating the Effects of Radiation Therapy and Chemotherapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic Glioma Start of enrollment: 2008 Jul 01
- Evaluating Tumor Pseudoprogression With FLT-PET and MRI Start of enrollment: 2011 May 01
- Amgen 386 for Recurrent Glioblastoma Start of enrollment: 2010 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- Clinical progress in the development of CAR T cells to treat malignant glioma.Eric P Grewal, Brian V Nahed, Bob S Carter, Elizabeth R Gerstner, William T Curry
Journal of Neuro-Oncology. 2025-02-01 - 1 citationsBrain volume loss after cranial irradiation: a controlled comparison study between photon vs proton radiotherapy for WHO grade 2-3 gliomas.Melissa M Gardner, Sebastian F Winter, Franziska Stahl, Elizabeth R Gerstner, Helen A Shih
Journal of Neuro-Oncology. 2025-01-01 - 1 citationsIvosidenib for the treatment of IDH1-mutant glioma, grades 2-4: Tolerability, predictors of response, and outcomes.Tyler A Lanman, Gilbert Youssef, Raymond Huang, Rifaquat Rahman, Matthew DeSalvo
Neuro-Oncology Advances. 2024-12-19
Journal Articles
- Phase I and Biomarker Study of Plerixafor and Bevacizumab in Recurrent High-Grade GliomaElizabeth Gerstner, Rakesh K Jain, Tracy Batchelor, Clinical Cancer Research
Press Mentions
Damon Runyon Cancer Research Foundation Announces 2021 Physician-Scientist AwardeesJune 3rd, 2021
Can Polio, a Killer Virus from the Past, Treat Cancer in the Present?July 2nd, 2018
A Brain Cancer "Warrior" Takes the Trip of a LifetimeFebruary 10th, 2016- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
